Some cancer cells have gene changes (also called mutations) that help them grow and spread. The NSCLC Drugs is to block those changes.
This report aims to provide a comprehensive presentation of the global market for NSCLC Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NSCLC Drugs. This report contains market size and forecasts of NSCLC Drugs in global, including the following market information:
Global NSCLC Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global NSCLC Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Oral Type Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of NSCLC Drugs include Merck, Bristol-Myers Squibb, Regeneron Pharmaceuticals, Novartis, Jiangsu Hengrui Medicine, Innovent Biologics, Shanghai Junshi Biosciences, BeiGene and Roche, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the NSCLC Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global NSCLC Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global NSCLC Drugs Market Segment Percentages, by Type, 2022 (%)
Oral Type
Injection Type
Global NSCLC Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global NSCLC Drugs Market Segment Percentages, by Application, 2022 (%)
Squamous Cell Lung Carcinoma
Large-cell Lung Carcinoma
Global NSCLC Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global NSCLC Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies NSCLC Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies NSCLC Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Bristol-Myers Squibb
Regeneron Pharmaceuticals
Novartis
Jiangsu Hengrui Medicine
Innovent Biologics
Shanghai Junshi Biosciences
BeiGene
Roche
AstraZeneca
Pfizer
Boehringer-Ingelheim
Teva
Outline of Major Chapters:
Chapter 1: Introduces the definition of NSCLC Drugs, market overview.
Chapter 2: Global NSCLC Drugs market size in revenue.
Chapter 3: Detailed analysis of NSCLC Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of NSCLC Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 NSCLC Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global NSCLC Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global NSCLC Drugs Overall Market Size
2.1 Global NSCLC Drugs Market Size: 2022 VS 2029
2.2 Global NSCLC Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top NSCLC Drugs Players in Global Market
3.2 Top Global NSCLC Drugs Companies Ranked by Revenue
3.3 Global NSCLC Drugs Revenue by Companies
3.4 Top 3 and Top 5 NSCLC Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies NSCLC Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 NSCLC Drugs Players in Global Market
3.6.1 List of Global Tier 1 NSCLC Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 NSCLC Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global NSCLC Drugs Market Size Markets, 2022 & 2029
4.1.2 Oral Type
4.1.3 Injection Type
4.2 By Type - Global NSCLC Drugs Revenue & Forecasts
4.2.1 By Type - Global NSCLC Drugs Revenue, 2018-2023
4.2.2 By Type - Global NSCLC Drugs Revenue, 2024-2029
4.2.3 By Type - Global NSCLC Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global NSCLC Drugs Market Size, 2022 & 2029
5.1.2 Squamous Cell Lung Carcinoma
5.1.3 Large-cell Lung Carcinoma
5.2 By Application - Global NSCLC Drugs Revenue & Forecasts
5.2.1 By Application - Global NSCLC Drugs Revenue, 2018-2023
5.2.2 By Application - Global NSCLC Drugs Revenue, 2024-2029
5.2.3 By Application - Global NSCLC Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global NSCLC Drugs Market Size, 2022 & 2029
6.2 By Region - Global NSCLC Drugs Revenue & Forecasts
6.2.1 By Region - Global NSCLC Drugs Revenue, 2018-2023
6.2.2 By Region - Global NSCLC Drugs Revenue, 2024-2029
6.2.3 By Region - Global NSCLC Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America NSCLC Drugs Revenue, 2018-2029
6.3.2 US NSCLC Drugs Market Size, 2018-2029
6.3.3 Canada NSCLC Drugs Market Size, 2018-2029
6.3.4 Mexico NSCLC Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe NSCLC Drugs Revenue, 2018-2029
6.4.2 Germany NSCLC Drugs Market Size, 2018-2029
6.4.3 France NSCLC Drugs Market Size, 2018-2029
6.4.4 U.K. NSCLC Drugs Market Size, 2018-2029
6.4.5 Italy NSCLC Drugs Market Size, 2018-2029
6.4.6 Russia NSCLC Drugs Market Size, 2018-2029
6.4.7 Nordic Countries NSCLC Drugs Market Size, 2018-2029
6.4.8 Benelux NSCLC Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia NSCLC Drugs Revenue, 2018-2029
6.5.2 China NSCLC Drugs Market Size, 2018-2029
6.5.3 Japan NSCLC Drugs Market Size, 2018-2029
6.5.4 South Korea NSCLC Drugs Market Size, 2018-2029
6.5.5 Southeast Asia NSCLC Drugs Market Size, 2018-2029
6.5.6 India NSCLC Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America NSCLC Drugs Revenue, 2018-2029
6.6.2 Brazil NSCLC Drugs Market Size, 2018-2029
6.6.3 Argentina NSCLC Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa NSCLC Drugs Revenue, 2018-2029
6.7.2 Turkey NSCLC Drugs Market Size, 2018-2029
6.7.3 Israel NSCLC Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia NSCLC Drugs Market Size, 2018-2029
6.7.5 UAE NSCLC Drugs Market Size, 2018-2029
7 NSCLC Drugs Companies Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck NSCLC Drugs Major Product Offerings
7.1.4 Merck NSCLC Drugs Revenue in Global Market (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Company Summary
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb NSCLC Drugs Major Product Offerings
7.2.4 Bristol-Myers Squibb NSCLC Drugs Revenue in Global Market (2018-2023)
7.2.5 Bristol-Myers Squibb Key News & Latest Developments
7.3 Regeneron Pharmaceuticals
7.3.1 Regeneron Pharmaceuticals Company Summary
7.3.2 Regeneron Pharmaceuticals Business Overview
7.3.3 Regeneron Pharmaceuticals NSCLC Drugs Major Product Offerings
7.3.4 Regeneron Pharmaceuticals NSCLC Drugs Revenue in Global Market (2018-2023)
7.3.5 Regeneron Pharmaceuticals Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis NSCLC Drugs Major Product Offerings
7.4.4 Novartis NSCLC Drugs Revenue in Global Market (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Jiangsu Hengrui Medicine
7.5.1 Jiangsu Hengrui Medicine Company Summary
7.5.2 Jiangsu Hengrui Medicine Business Overview
7.5.3 Jiangsu Hengrui Medicine NSCLC Drugs Major Product Offerings
7.5.4 Jiangsu Hengrui Medicine NSCLC Drugs Revenue in Global Market (2018-2023)
7.5.5 Jiangsu Hengrui Medicine Key News & Latest Developments
7.6 Innovent Biologics
7.6.1 Innovent Biologics Company Summary
7.6.2 Innovent Biologics Business Overview
7.6.3 Innovent Biologics NSCLC Drugs Major Product Offerings
7.6.4 Innovent Biologics NSCLC Drugs Revenue in Global Market (2018-2023)
7.6.5 Innovent Biologics Key News & Latest Developments
7.7 Shanghai Junshi Biosciences
7.7.1 Shanghai Junshi Biosciences Company Summary
7.7.2 Shanghai Junshi Biosciences Business Overview
7.7.3 Shanghai Junshi Biosciences NSCLC Drugs Major Product Offerings
7.7.4 Shanghai Junshi Biosciences NSCLC Drugs Revenue in Global Market (2018-2023)
7.7.5 Shanghai Junshi Biosciences Key News & Latest Developments
7.8 BeiGene
7.8.1 BeiGene Company Summary
7.8.2 BeiGene Business Overview
7.8.3 BeiGene NSCLC Drugs Major Product Offerings
7.8.4 BeiGene NSCLC Drugs Revenue in Global Market (2018-2023)
7.8.5 BeiGene Key News & Latest Developments
7.9 Roche
7.9.1 Roche Company Summary
7.9.2 Roche Business Overview
7.9.3 Roche NSCLC Drugs Major Product Offerings
7.9.4 Roche NSCLC Drugs Revenue in Global Market (2018-2023)
7.9.5 Roche Key News & Latest Developments
7.10 AstraZeneca
7.10.1 AstraZeneca Company Summary
7.10.2 AstraZeneca Business Overview
7.10.3 AstraZeneca NSCLC Drugs Major Product Offerings
7.10.4 AstraZeneca NSCLC Drugs Revenue in Global Market (2018-2023)
7.10.5 AstraZeneca Key News & Latest Developments
7.11 Pfizer
7.11.1 Pfizer Company Summary
7.11.2 Pfizer Business Overview
7.11.3 Pfizer NSCLC Drugs Major Product Offerings
7.11.4 Pfizer NSCLC Drugs Revenue in Global Market (2018-2023)
7.11.5 Pfizer Key News & Latest Developments
7.12 Boehringer-Ingelheim
7.12.1 Boehringer-Ingelheim Company Summary
7.12.2 Boehringer-Ingelheim Business Overview
7.12.3 Boehringer-Ingelheim NSCLC Drugs Major Product Offerings
7.12.4 Boehringer-Ingelheim NSCLC Drugs Revenue in Global Market (2018-2023)
7.12.5 Boehringer-Ingelheim Key News & Latest Developments
7.13 Teva
7.13.1 Teva Company Summary
7.13.2 Teva Business Overview
7.13.3 Teva NSCLC Drugs Major Product Offerings
7.13.4 Teva NSCLC Drugs Revenue in Global Market (2018-2023)
7.13.5 Teva Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. NSCLC Drugs Market Opportunities & Trends in Global Market
Table 2. NSCLC Drugs Market Drivers in Global Market
Table 3. NSCLC Drugs Market Restraints in Global Market
Table 4. Key Players of NSCLC Drugs in Global Market
Table 5. Top NSCLC Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global NSCLC Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global NSCLC Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies NSCLC Drugs Product Type
Table 9. List of Global Tier 1 NSCLC Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 NSCLC Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global NSCLC Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - NSCLC Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - NSCLC Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global NSCLC Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - NSCLC Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - NSCLC Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global NSCLC Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global NSCLC Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global NSCLC Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America NSCLC Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America NSCLC Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe NSCLC Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe NSCLC Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia NSCLC Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia NSCLC Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America NSCLC Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America NSCLC Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa NSCLC Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa NSCLC Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Merck Company Summary
Table 31. Merck NSCLC Drugs Product Offerings
Table 32. Merck NSCLC Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Merck Key News & Latest Developments
Table 34. Bristol-Myers Squibb Company Summary
Table 35. Bristol-Myers Squibb NSCLC Drugs Product Offerings
Table 36. Bristol-Myers Squibb NSCLC Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Bristol-Myers Squibb Key News & Latest Developments
Table 38. Regeneron Pharmaceuticals Company Summary
Table 39. Regeneron Pharmaceuticals NSCLC Drugs Product Offerings
Table 40. Regeneron Pharmaceuticals NSCLC Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Regeneron Pharmaceuticals Key News & Latest Developments
Table 42. Novartis Company Summary
Table 43. Novartis NSCLC Drugs Product Offerings
Table 44. Novartis NSCLC Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Novartis Key News & Latest Developments
Table 46. Jiangsu Hengrui Medicine Company Summary
Table 47. Jiangsu Hengrui Medicine NSCLC Drugs Product Offerings
Table 48. Jiangsu Hengrui Medicine NSCLC Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Jiangsu Hengrui Medicine Key News & Latest Developments
Table 50. Innovent Biologics Company Summary
Table 51. Innovent Biologics NSCLC Drugs Product Offerings
Table 52. Innovent Biologics NSCLC Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Innovent Biologics Key News & Latest Developments
Table 54. Shanghai Junshi Biosciences Company Summary
Table 55. Shanghai Junshi Biosciences NSCLC Drugs Product Offerings
Table 56. Shanghai Junshi Biosciences NSCLC Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Shanghai Junshi Biosciences Key News & Latest Developments
Table 58. BeiGene Company Summary
Table 59. BeiGene NSCLC Drugs Product Offerings
Table 60. BeiGene NSCLC Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. BeiGene Key News & Latest Developments
Table 62. Roche Company Summary
Table 63. Roche NSCLC Drugs Product Offerings
Table 64. Roche NSCLC Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Roche Key News & Latest Developments
Table 66. AstraZeneca Company Summary
Table 67. AstraZeneca NSCLC Drugs Product Offerings
Table 68. AstraZeneca NSCLC Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. AstraZeneca Key News & Latest Developments
Table 70. Pfizer Company Summary
Table 71. Pfizer NSCLC Drugs Product Offerings
Table 72. Pfizer NSCLC Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Pfizer Key News & Latest Developments
Table 74. Boehringer-Ingelheim Company Summary
Table 75. Boehringer-Ingelheim NSCLC Drugs Product Offerings
Table 76. Boehringer-Ingelheim NSCLC Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Boehringer-Ingelheim Key News & Latest Developments
Table 78. Teva Company Summary
Table 79. Teva NSCLC Drugs Product Offerings
Table 80. Teva NSCLC Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Teva Key News & Latest Developments
List of Figures
Figure 1. NSCLC Drugs Segment by Type in 2022
Figure 2. NSCLC Drugs Segment by Application in 2022
Figure 3. Global NSCLC Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global NSCLC Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global NSCLC Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by NSCLC Drugs Revenue in 2022
Figure 8. By Type - Global NSCLC Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global NSCLC Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global NSCLC Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global NSCLC Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global NSCLC Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global NSCLC Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global NSCLC Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America NSCLC Drugs Revenue Market Share, 2018-2029
Figure 16. US NSCLC Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada NSCLC Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico NSCLC Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe NSCLC Drugs Revenue Market Share, 2018-2029
Figure 20. Germany NSCLC Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France NSCLC Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. NSCLC Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy NSCLC Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia NSCLC Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries NSCLC Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux NSCLC Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia NSCLC Drugs Revenue Market Share, 2018-2029
Figure 28. China NSCLC Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan NSCLC Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea NSCLC Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia NSCLC Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India NSCLC Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America NSCLC Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil NSCLC Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina NSCLC Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa NSCLC Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey NSCLC Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel NSCLC Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia NSCLC Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE NSCLC Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Merck NSCLC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bristol-Myers Squibb NSCLC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Regeneron Pharmaceuticals NSCLC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novartis NSCLC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Jiangsu Hengrui Medicine NSCLC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Innovent Biologics NSCLC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Shanghai Junshi Biosciences NSCLC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. BeiGene NSCLC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Roche NSCLC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. AstraZeneca NSCLC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Pfizer NSCLC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Boehringer-Ingelheim NSCLC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Teva NSCLC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
